The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bumpus Namandje since 2026.
This trader's CIK number is 2060594.
At the time of last reporting, Bumpus Namandje was the Director of Recursion Pharmaceuticals, Inc.. (stock ticker symbol RXRX).
Also see all insider trading activities at Recursion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | RXRX | 0 | $0 | 4,386 | $15,526 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-03 | RXRX | Sale | 4,386 | 3.54 | 15,526 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bumpus Namandje (Director of Recursion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.